Exploiting synthetic lethality in Renal Cell Carcinoma: Targeting the loss of the von Hippel-Lindau tumor suppressor gene through autophagy for the development of anticancer therapy
Turcotte, Sandra
4 enregistrements totalisant 844,930.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $800,930 | 3 enregistrements |
| Conseil de recherches en sciences naturelles et en génie du Canada | $44,000 | 1 enregistrement |
Enregistrements
TURCOTTE, Sandra
$495,930.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2014-2015
Canada
TURCOTTE, Sandra
$205,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
Targeting the loss of the von Hippel-Lindau tumor suppressor gene at a late-stage of autophagy for the development of anticancer therapy
Turcotte, Sandra
$100,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2022-2023
Canada
• The CIHR Institute of Cancer (CIHR-ICR) will provide funding for applications that are determined to be relevant to its mandate: o The Institute of Cancer Research (ICR) supports research that redu...
Turcotte, Sandra
$44,000.00
Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada
Discovery Research
EF 2026-2027
Canada
The Discovery Development Grants (DDG) pilot is a complementary program element to the Discovery Grants (DG) Program. The program aims to promote and maintain a diversified base of high-quality resear...